心血管診断・モニタリング機器のグローバル市場(2022-2031):心電図機器、ホルターモニター、イベントモニター、植込み型ループレコーダー、その他

• 英文タイトル:Cardiovascular Diagnostic & Monitoring Devices Market (Product: ECG Devices, Holter Monitors, Event Monitors, Implantable Loop Recorders, and Mobile Cardiac Telemetry) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Cardiovascular Diagnostic & Monitoring Devices Market (Product: ECG Devices, Holter Monitors, Event Monitors, Implantable Loop Recorders, and Mobile Cardiac Telemetry) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031「心血管診断・モニタリング機器のグローバル市場(2022-2031):心電図機器、ホルターモニター、イベントモニター、植込み型ループレコーダー、その他」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2301D030
• 出版社/出版日:Transparency Market Research / 2022年11月25日
• レポート形態:英文、PDF、153ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥869,250 (USD5,795)▷ お問い合わせ
  Multi User¥1,319,250 (USD8,795)▷ お問い合わせ
  Corporate License¥1,769,250 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の市場調査レポートでは、世界の心血管診断・モニタリング機器市場の現状について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、製品別(心電図機器、ホルターモニター、イベントモニター、植込み型ループレコーダー、その他)分析、エンドユーザー別(病院、診療所、外来手術センター、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況など、以下の構成でお届けします。また、当レポートに掲載されている企業情報には、Abbott Laboratories、Biotronik、Boston Scientific Corporation、GE Healthcare、Medtronic、Nihon Kohden Corporationなどが含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・主要インサイト
・世界の心血管診断・モニタリング機器市場規模:製品別
- 心電図機器の市場規模
- ホルターモニターの市場規模
- イベントモニターの市場規模
- 植込み型ループレコーダーの市場規模
- その他心血管診断・モニタリング機器の市場規模
・世界の心血管診断・モニタリング機器市場規模:エンドユーザー別
- 病院における市場規模
- 診療所における市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の心血管診断・モニタリング機器市場規模:地域別
- 北米の心血管診断・モニタリング機器市場規模
- ヨーロッパの心血管診断・モニタリング機器市場規模
- アジア太平洋の心血管診断・モニタリング機器市場規模
- 中南米の心血管診断・モニタリング機器市場規模
- 中東・アフリカの心血管診断・モニタリング機器市場規模
・競争状況

Cardiovascular Diagnostic & Monitoring Devices Market – Scope of Report
TMR’s report on the global cardiovascular diagnostic & monitoring devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global cardiovascular diagnostic & monitoring devices market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cardiovascular diagnostic & monitoring devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the cardiovascular diagnostic & monitoring devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cardiovascular diagnostic & monitoring devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global cardiovascular diagnostic & monitoring devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cardiovascular diagnostic & monitoring devices market.

The report delves into the competitive landscape of the global cardiovascular diagnostic & monitoring devices market. Key players operating in the global cardiovascular diagnostic & monitoring devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cardiovascular diagnostic & monitoring devices market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market cardiovascular diagnostic & monitoring devices.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cardiovascular Diagnostic & Monitoring Devices Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, 2017–2031
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Disease Prevalence & Incidence Rate
5.2. Key Product/Brand Analysis
5.3. Smart wearable devices in cardiovascular care: where we are and how to move forward
5.4. Value Chain Analysis
5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. ECG Devices
6.3.1.1. Resting ECG Devices
6.3.1.2. Stress ECG Devices
6.3.2. Holter Monitors
6.3.3. Event Monitors
6.3.4. Implantable Loop Recorders
6.3.5. Mobile Cardiac Telemetry
6.4. Market Attractiveness Analysis, by Product
7. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Ambulatory Surgery Centers
7.3.4. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2031
9.2.1. ECG Devices
9.2.1.1. Resting ECG Devices
9.2.1.2. Stress ECG Devices
9.2.2. Holter Monitors
9.2.3. Event Monitors
9.2.4. Implantable Loop Recorders
9.2.5. Mobile Cardiac Telemetry
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Ambulatory Surgery Centers
9.3.4. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. ECG Devices
10.2.1.1. Resting ECG Devices
10.2.1.2. Stress ECG Devices
10.2.2. Holter Monitors
10.2.3. Event Monitors
10.2.4. Implantable Loop Recorders
10.2.5. Mobile Cardiac Telemetry
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Clinics
10.3.3. Ambulatory Surgery Centers
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. ECG Devices
11.2.1.1. Resting ECG Devices
11.2.1.2. Stress ECG Devices
11.2.2. Holter Monitors
11.2.3. Event Monitors
11.2.4. Implantable Loop Recorders
11.2.5. Mobile Cardiac Telemetry
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Clinics
11.3.3. Ambulatory Surgery Centers
11.3.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. ECG Devices
12.2.1.1. Resting ECG Devices
12.2.1.2. Stress ECG Devices
12.2.2. Holter Monitors
12.2.3. Event Monitors
12.2.4. Implantable Loop Recorders
12.2.5. Mobile Cardiac Telemetry
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Clinics
12.3.3. Ambulatory Surgery Centers
12.3.4. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. ECG Devices
13.2.1.1. Resting ECG Devices
13.2.1.2. Stress ECG Devices
13.2.2. Holter Monitors
13.2.3. Event Monitors
13.2.4. Implantable Loop Recorders
13.2.5. Mobile Cardiac Telemetry
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Clinics
13.3.3. Ambulatory Surgery Centers
13.3.4. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2021
14.3. Competitive Business Strategies
14.4. Company Profiles
14.4.1. Abbott Laboratories
14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.1.2. Company Financials
14.4.1.3. Growth Strategies
14.4.1.4. SWOT Analysis
14.4.2. Biotronik
14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.2.2. Company Financials
14.4.2.3. Growth Strategies
14.4.2.4. SWOT Analysis
14.4.3. Boston Scientific Corporation
14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.3.2. Company Financials
14.4.3.3. Growth Strategies
14.4.3.4. SWOT Analysis
14.4.4. GE Healthcare
14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.4.2. Company Financials
14.4.4.3. Growth Strategies
14.4.4.4. SWOT Analysis
14.4.5. Medtronic
14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.5.2. Company Financials
14.4.5.3. Growth Strategies
14.4.5.4. SWOT Analysis
14.4.6. Nihon Kohden Corporation
14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.6.2. Company Financials
14.4.6.3. Growth Strategies
14.4.6.4. SWOT Analysis




• 英文レポート名:Cardiovascular Diagnostic & Monitoring Devices Market (Product: ECG Devices, Holter Monitors, Event Monitors, Implantable Loop Recorders, and Mobile Cardiac Telemetry) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
• 日本語訳:心血管診断・モニタリング機器のグローバル市場(2022-2031):心電図機器、ホルターモニター、イベントモニター、植込み型ループレコーダー、その他
• レポートコード:MRC2301D030お問い合わせ(見積依頼・ご注文・質問)